Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19
Ann Rheum Dis
.
2020 Jun;79(6):737-739.
doi: 10.1136/annrheumdis-2020-217460.
Epub 2020 Apr 15.
Authors
Chenyang Lu
#
1
,
Shasha Li
#
2
,
Yi Liu
3
Affiliations
1
Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
2
Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.
3
Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China Yi2006liu@163.com.
#
Contributed equally.
PMID:
32295789
DOI:
10.1136/annrheumdis-2020-217460
No abstract available
Keywords:
antirheumatic agents; cytokines; inflammation.
Publication types
Review
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections
Humans
Kidney Transplantation*
Pandemics
Pneumonia, Viral*
Rheumatic Diseases*
SARS-CoV-2